Woodline Partners’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.41M | Hold |
|
|||||
|
2025
Q2 | $4.93M | Hold |
|
|||||
|
2025
Q1 | $6.37M | Buy |
|
|||||
|
2024
Q4 | $9.29M | Sell |
|
|||||
|
2024
Q3 | $12.2M | Buy |
|
|||||
|
2024
Q2 | $10.2M | Buy |
|
|||||
|
2024
Q1 | $11.8M | Buy |
|
|||||
|
2023
Q4 | $8.27M | Sell |
|
|||||
|
2023
Q3 | $16.8M | Buy |
|
|||||
|
2023
Q2 | $26.4M | Buy |
|
|||||
|
2023
Q1 | $10.8M | Sell |
|
|||||
|
2022
Q4 | $18.4M | Sell |
|
|||||
|
2022
Q3 | $48.9M | Sell |
|
|||||
|
2022
Q2 | $66.8M | Buy |
|
|||||
|
2022
Q1 | $3.94M | Sell |
|
|||||
|
2021
Q4 | $7.46M | Sell |
|
|||||
|
2021
Q3 | $20.9M | Buy |
|
|||||
|
2021
Q2 | $17.9M | Buy |
|
|||||
|
2021
Q1 | $23.7M | Buy |
|
|||||
|
2020
Q4 | $14.3M | Buy |
|
|||||
|
2020
Q3 | $15.1M | Buy |
|
|||||
|
2020
Q2 | $5.51M | Buy |
|